JPRN-jRCT2031220536已完成1 期
Pharmacokinetic study of HP-6050
Inakura Hiroshi0 个研究点目标入组 60 人开始时间: 2022年12月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Healthy Japanese adults aged >=18 and <65 years, or healthy Japanese elderly aged >=65 years (at the time of informed consent)
排除标准
- •- Subjects with current or history of serious cardiac, vascular, renal, hepatic, psychiatric/neurological, or metabolic diseases
- •- Subjects who received any drug within a week prior to application of the study drug
研究者
相似试验
已完成
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223788Hisamitsu Pharmaceutical Co., Inc.24
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.
已完成
1 期
A single-dose study of HP-6050Healthy adultJPRN-jRCT2031220092Inakura Hiroshi16
未知
1 期
Pharmacokinetic study of DSP-1958pediatric solid tumor, pediatric brain tumor, malignamt lymphomaJPRN-jRCT2080223378Sumitomo Dainippon Pharma Co., Ltd.15
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.